158 related articles for article (PubMed ID: 29392121)
1. Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran.
Abedi AR; Fallah-Karkan M; Allameh F; Ranjbar A; Shadmehr A
Res Rep Urol; 2018; 10():1-6. PubMed ID: 29392121
[TBL] [Abstract][Full Text] [Related]
2. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
3. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract][Full Text] [Related]
4. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia.
Kizilkan Y; Eroglu U; Senel S; Yildizhan M; Balci M; Aykanat IC; Aktas BK; Bulut S; Guzel O; Gokkaya CS; Aslan Y; Ozden C; Tuncel A
Andrologia; 2022 Feb; 54(1):e14261. PubMed ID: 34590345
[TBL] [Abstract][Full Text] [Related]
7. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
[TBL] [Abstract][Full Text] [Related]
8. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
9. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
11. The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review.
Abedi AR; Ghiasy S; Fallah-Karkan M; Rahavian A; Allameh F
Res Rep Urol; 2020; 12():105-109. PubMed ID: 32215268
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia.
Hosseini SY; Salimi M; Hosseini Moghaddam SM
Urol J; 2005; 2(4):183-8. PubMed ID: 17602426
[TBL] [Abstract][Full Text] [Related]
13. [Importance of PSA velocity and PSA density in the prediction of prostate cancer in TURP or open prostatectomy specimen of patients with previous negative prostate biopsy].
Rodríguez Alonso A; González Blanco A; Barbagelata López A; Pita Fernández S; Suárez Pascual G; Bonelli Martín C; Cuerpo Pérez M
Actas Urol Esp; 2008 Sep; 32(8):779-86. PubMed ID: 19013975
[TBL] [Abstract][Full Text] [Related]
14. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
[TBL] [Abstract][Full Text] [Related]
17. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
[TBL] [Abstract][Full Text] [Related]
18. Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?
Skrzypczyk MA; Dobruch J; Nyk L; Szostek P; Szempliński S; Borówka A
Cent European J Urol; 2014; 67(3):227-32. PubMed ID: 25247076
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer.
Lambert E; Goossens M; Palagonia E; Vollemaere J; Mazzone E; Dell'Oglio P; Pauwels E; De Groote R; D'Hondt F; Mottrie A; De Naeyer G; Schatteman P
World J Urol; 2021 Jul; 39(7):2621-2626. PubMed ID: 32997261
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
